Dr. Andreas Hahne is a German qualified attorney (Rechtsanwalt) and Partner in Quinn Emanuel’s Munich office. He joined the firm in 2016. His practice covers all fields of complex tech litigation with a focus on patent litigation. He also advises clients in disputes involving FRAND licensing and in antitrust and competition law matters.
Andreas represents clients before the Unified Patent Court (UPC) and the major German patent infringement courts at trial and appellate level, in nullity proceedings before the German Federal Patent Court and the Federal Supreme Court, and in opposition proceedings at the European Patent Office (EPO) before the Opposition Divisions and the Technical Boards of Appeal. He has extensive experience in cross-border cases involving the coordination of various jurisdictions. His expertise covers a broad range of industries and technologies such as life sciences, biotech, pharmaceuticals, IT, telecommunications, speech and video coding, semiconductors, and automotive.
Andreas holds degrees of the University of Erlangen-Nuremburg (JD equivalent) and Queen Mary University of London (LL.M.). He obtained his doctorate degree (Ph.D.) in law from the University of Munich.
From 2023 to 2025, Legal 500 Deutschland and Legal 500 EMEA named him a “Recommended Lawyer for Intellectual Property: Patent Litigation”. From 2020 - 2025, Managing IP’s IP Stars has recognized Andreas as a “Rising Star”. He has been ranked by The Best Lawyers in Germany (Ones to Watch) /Handelsblatt for Competition / Antitrust Law (2022 – 2024) and for Litigation (2025-2026). In 2024 and 2025 Leaders League ranked him as “Leading” for patent litigation in Germany.
- Daimler/Mercedes-Benz
- Dexcom
- Halozyme
- Niantic
- Qualcomm
- Samsung Bioepis
- Tesla
- Representation of Google against Sonos, Ona Patents, and others in patent litigation.
- Representation of Samsung Bioepis against Regeneron and Bayer in patent litigation.
- Representation of Halozyme against Merck Sharp & Dohme (MSD) in patent litigation.
- Advice of a global pharmaceutical company regarding its freedom-to-operate strategy for two biosimilars.
- Representation of Daimler against Nokia, Sharp, and Conversant Wireless in patent litigation.
- Representation of Dexcom against Abbott in patent litigation.
- Representation of Qualcomm against Apple in patent litigation.
- Representation of Niantic against K.Mizra in patent litigation.
- Representation of a leading biotech company in its German patent litigation campaign.
- Higher Regional Court of Munich
(Second State Examination, 2016) - Ludwig Maximilian University of Munich
(Ph.D., Law (Dr. jur.), summa cum laude, 2015) - Queen Mary University of London
(LL.M., 2012) - Friedrich Alexander University of Erlangen-Nuremberg
(First State Examination, 2011)
- The German Bar (Rechtsanwaltskammer München)
- German
- English
- Leaders League – “Leading” for Patent Litigation in Germany (2024-2025)
- Legal 500 Deutschland and Legal 500 EMEA – Lawyer for Intellectual Property: Patent Litigation by Legal 500 Deutschland (2023-2025)
- The Best Lawyers in Germany (Ones to Watch)/Handelsblatt – Competition/ Antitrust Law (2022-2024) and Litigation (2025-2026).
- Managing IP’s IP Stars – “Rising Star” (2020-2025)
- IAM Patent 1000 – 'Next Generation: Recommended' for patent litigation in Germany (2025)
- BeckOK ZPO, commentary of Art. 68, 70, 71, 71b, 71d Brussels I-bis Regulation, published by Dr. Volkert Vorwerk, Dr. Christian Wolf, C.H. Beck, Munich 2025
- “Limiting Automatic Injunctions in Patent Law: Disproportionality under the UPC Regime”, Mannheim Competition Law Policy Forum, September 2024
- “Das Erfordernis der Marktabgrenzung aus rechtlicher und ökonomischer Sicht”, Nomos, 2016
- Member, GRUR (German Association for the Protection of Intellectual Property)